Provided by Tiger Trade Technology Pte. Ltd.

Vaxcyte, Inc.

66.96
+0.26000.39%
Post-market: 66.64-0.3200-0.48%19:47 EDT
Volume:11.56M
Turnover:763.14M
Market Cap:9.96B
PE:-8.75
High:67.15
Open:65.86
Low:64.27
Close:66.70
52wk High:90.75
52wk Low:39.87
Shares:148.81M
Float Shares:136.00M
Volume Ratio:1.92
T/O Rate:8.50%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-7.6496
EPS(LYR):-5.6333
ROE:-36.51%
ROA:-22.61%
PB:3.61
PE(LYR):-11.89

Loading ...

Vaxcyte SVP Finance, CAO Elvia Cowan Disposes of 19,000 Common Shares for $1,647,060

Reuters
·
3 hours ago

US Stocks on the MOVE-Halozyme, Moderna, Merck

Reuters
·
5 hours ago

U.S. Stocks on the MOVE-Halozyme, BKV, AppFolio

Reuters
·
7 hours ago

Analysts Conflicted on These Healthcare Names: BridgeBio Pharma (BBIO) and Vaxcyte (PCVX)

TIPRANKS
·
Yesterday

U.S. Stocks on the MOVE-Intel, Vaxcyte, Constellation Brands

Reuters
·
Yesterday

Vaxcyte 7.412M share Spot Secondary priced at $64.00

TIPRANKS
·
Yesterday

Why Vaxcyte Chose A 1.5% Convertible

Macro World​
·
Yesterday

Vaxcyte Announces Pricing of Public Offerings and $500 Million Convertible Notes Due 2032

Reuters
·
Yesterday

Vaxcyte Prices USD 500 Million Convertible Senior Notes Offering Due 2032

Reuters
·
Yesterday

Vaxcyte - Common Stock Offered at $64 Per Share; Pre-Funded Warrants at $64; Exercise Price $0.001

THOMSON REUTERS
·
Yesterday

Vaxcyte - Announces Pricing of Public Offerings and $500 Mln Convertible Notes Due 2032

THOMSON REUTERS
·
Yesterday

Vaxcyte Announces Pricing of Concurrent Public Offerings of Common Stock, Pre-Funded Warrants and Convertible Senior Notes

THOMSON REUTERS
·
Yesterday

Market Movers | Option Care Health Surges 33%; SpaceX Gains 2%; Nvidia Rises 1%; SK hynix Falls 3%

Tiger Newspress
·
Oct 06

Movement Alert|Vaxcyte, Inc. Falls 5.92% in Regular Trading, Equity Dilution Concerns Following Public Offering Announcement

Market Focus
·
Oct 06

Vaxcyte Down After Starting $1 Bln Stock, Convertible Offerings

Reuters
·
Oct 06

US Research Roundup-Affiliated Managers Group, Goldman Sachs, Vaxcyte

Reuters
·
Oct 06

Vaxcyte Shares Fall 3.4% Premarket After Co Commences Public Offering of Stock, Warrants and Convertible Notes

THOMSON REUTERS
·
Oct 06

Lonza to Add New Revenue Driver with Vaxcyte's Pneumonia Shot

Dow Jones
·
Oct 06

Vaxcyte, Inc. : Needham Raises Target Price to $122 from $110

THOMSON REUTERS
·
Oct 06

Movement Alert|Vaxcyte, Inc. After-Hours Decline 5.39%, New Share Offering Sparks Dilution Concerns

Market Focus
·
Oct 06